This study was designed to test the hypothesis that the antikaliuresis
caused by trimethoprim could be diminished by alkalinizing the lumina
l fluid in the CCD, thereby converting trimethoprim from its cationic,
active form to an electroneutral, inactive form. Timethoprim-induced
inhibition of transepithelial Na+ transport was examined in A6 distal
nephron cells by analysis of short circuit current. The voltage-depend
ence of the trimethoprim-induced block of Na+ channels was examined wi
th patch clamp recordings of A6 cells. The antikaliuretic effect of tr
imethoprim was examined in vivo in rats pretreated with desoxycorticos
terone and with NH4Cl to lower urine pH, and in rats also receiving ac
etazoiamide to raise urine pH. We found that the concentration of trim
ethoprim required to inhibit the amiloride sensitive component of shor
t circuit current by 50% (IC50) was 340 mu M (at pH 8.2) and 50 mu M (
at pH 6.3). The IC(50)s of protonated trimethoprim were similar (34 mu
M at PH 8.2 and 45 mu M at pH 6.3). The mean time open for the high s
electivity, Na+ channel was reduced from 1679 +/- 387 msec to 502 +/-
98 msec with addition of 10(-5) M trimethoprim to patch pipette soluti
on at the resting membrane potential (-V-pipette = 0 mV). Further decr
eases in mean time open were observed as -V-pipette was reduced (that
is, apical membrane hyperpolarization) to -40 mV (mean time open = 217
+/- 85 msec) and to -80 mV (mean time open = 69 +/- 13 msec). In vivo
, trimethoprim caused a > 50% reduction in potassium (K+) excretion du
e primarily to a fall in the [K+] in the lumen of the terminal CCD. Th
is effect of trimethoprim was markedly attenuated in an alkaline urine
induced by acetazolamide. We conclude that it is the charged, protona
ted species of trimethoprim which blocks epithelial Na+ channels. Incr
easing urinary pH decreases the concentration of the charged species o
f trimethoprim and minimizes its antikaliuretic effect.